Showing results (1-10 of 34) with videos related to
Sort By:
Pageof 4
The American Journal of Medicine|October 24, 1986
Pharmacodynamics of famotidine in humansA N ChremosJournal of Clinical Gastroenterology|January 1, 1987
Clinical pharmacology of famotidine: a summaryA N ChremosThe Journal of Pharmacology and Experimental Therapeutics|March 1, 1984
Comparison of the effects of sulindac with other cyclooxygenase inhibitors on prostaglandin excretion and renal function in normal and chronic bile duct-ligated dogs and swineE J Zambraski, A N Chremos, M J DunnThe American Journal of Medicine|October 24, 1986
Comparison of effects of oral and intravenous famotidine on inhibition of nocturnal gastric acid secretionJ R Ryan, R Vargas, F G McMahon, et al.Digestive Diseases and Sciences|April 1, 1985
Famotidine, a new H2-receptor antagonist. Effect on parietal, nonparietal, and pepsin secretion in manJ L Smith, M A Gamal, A N Chremos, et al.Journal of Clinical Pharmacology|February 1, 1978
An apomorphine-induced vomiting model for antiemetic studies in manJ D Proctor, A N Chremos, E F Evans, et al.The American Journal of Cardiology|March 20, 1990
Clinical experience with lovastatinJ A Tobert, C L Shear, A N Chremos, et al.Journal of Pharmaceutical Sciences|January 1, 1976
Time-dependent change in renal clearance of bethanidine in humansA N Chremos, D Shen, M Gibaldi, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 1, 1976
Disposition of bethanidine, N-benzyl-N',N''-dimethylguanidine, in the rat, dog and manL B Turnbull, L Teng, J Newman, et al.British Journal of Clinical Pharmacology|November 1, 1987
Comparative effect of famotidine and cimetidine on the pharmacokinetics of theophylline in normal volunteersJ H Lin, A N Chremos, R Chiou, et al.Pageof 4